Filters
Metformin treatment prior to conception is associated with a reduced risk for severe nausea and vomiting during pregnancy, according to new research.
Acute dengue virus (DENV) infection appears to be associated with an increased likelihood of new-onset neurologic events, although the overall increase appears modest, according to a retrospective study from Singapore.
Gay men and bisexual individuals are more likely to have risky sexual behaviours and experience sexual victimization, sexual dysfunctions, and other adverse outcomes than lesbians, reports a Danish study.
Patients with cirrhosis using calcium channel blockers (CCBs) are not at increased risk of variceal haemorrhage, as reported in a retrospective study.
Treatment with telitacicept reduces proteinuria among patients with immunoglobulin A nephropathy (IgAN) compared with placebo, according to a phase III study presented at ASN Kidney Week 2025.
For individuals with persisting COVID-19 symptoms, a 3-month resistance exercise program appears to yield greater improvements in physical function and psychological well-being compared with usual care alone, as shown in a study.
Treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) results in a decrease in deaths and major adverse cardiovascular events (MACE) in high-risk patients, reports as study.
Exposure to adverse childhood experiences (ACEs) appears to result in developmental, academic, and behavioural concerns among kindergarten children, suggests a Singapore study.
Patients with persistent symptoms of achalasia may benefit from repeat per-oral endoscopic myotomy (POEM) following a failed initial procedure, suggests a study.
In the post hoc analysis of the phase III PROTECT trial, the non-immunosuppressive dual endothelin angiotensin receptor antagonist sparsentan remains superior to irbesartan for the treatment of immunoglobulin A nephropathy (IgAN).